Welcome to our dedicated page for NewcelX SEC filings (Ticker: NCEL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NewcelX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NewcelX's regulatory disclosures and financial reporting.
NewcelX Ltd. (NLSP) reports auditor changes following its merger with Kadimastem. As part of post-merger integration, Kadimastem’s longtime auditor, Kost Forrer Gabbay & Kasierer, a member of Ernst & Young (EY), was appointed on November 20, 2025 as NewcelX’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
On November 17, 2025, after Audit Committee approval, the company dismissed CBIZ CPAs, P.C., which had replaced Marcum LLP on September 17, 2025 when CBIZ acquired Marcum’s attestation business. CBIZ CPAs did not issue an audit report on NewcelX’s financial statements. During CBIZ CPAs’ brief engagement there were no disagreements on accounting or auditing matters and no reportable events, other than previously disclosed material weaknesses in internal control related to staffing and segregation of duties.
The company notes that during the past two fiscal years and through November 20, 2025, it did not consult EY on specific accounting treatments or audit opinions and had no disagreements or reportable events with EY. CBIZ CPAs has provided a confirming letter to the SEC, filed as Exhibit 16.1.
FAQ
What is the current stock price of NewcelX (NCEL)?
What is the market cap of NewcelX (NCEL)?
